Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-97-003963
Filing Date
1997-09-26
Accepted
1997-09-26 00:00:00
Documents
13
Period of Report
1997-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 IMMUNOGEN, INC. 10-K405 181682
2 DESIGNATION OF SERIES D PREFERRED STOCK EX-4.5 44556
3 LEASE DATED 0/15/97 EX-10.7 72092
4 CONFIRMATORY 2ND AMENDMENT TO LEASE EX-10.10 2931
5 RESEARCH COLLABORATION AGREEMENT EX-10.32 79685
6 LICENSE AGREEMENT DATED 07/31/97 EX-10.33 84326
7 STOCK PURCHASE AGEEMENT EX-10.34 130592
8 REGISTRATION AGREEMENT WITH BIOCHEM EX-10.35 31603
9 REGISTRATION AGREEMENT WITH APOPTISIS EX-10.36 32039
10 FORM OF WARRANT EX-10.37 40471
11 SUBSIDIARIES OF THE REGISTRANT EX-21 249
12 CONSENT OF COOPERS & LYBRAND LLP EX-23 924
13 FINANCIAL DATA SCHEDULE EX-27 2002
  Complete submission text file 0000950135-97-003963.txt   705857
Mailing Address 148 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 333 PROVIDENCE HIGHWAY NORWOOD MA 02062 6176619312
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-K405 | Act: 34 | File No.: 000-17999 | Film No.: 97686403
SIC: 2834 Pharmaceutical Preparations